Rankings
▼
Calendar
PTCT Q4 2022 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PTCT
PTC Therapeutics, Inc.
$6B
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$167M
+1.3% YoY
Gross Profit
$157M
93.5% margin
Operating Income
-$200M
-119.7% margin
Net Income
-$171M
-102.1% margin
EPS (Diluted)
$-2.35
QoQ Revenue Growth
-22.9%
Cash Flow
Operating Cash Flow
-$166M
Free Cash Flow
-$193M
Stock-Based Comp.
$27M
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$2.1B
Stockholders' Equity
-$347M
Cash & Equivalents
$280M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$167M
$165M
+1.3%
Gross Profit
$157M
$156M
+0.4%
Operating Income
-$200M
-$85M
-136.4%
Net Income
-$171M
-$143M
-19.3%
Geographic Segments
United States
$58M
51%
Non-US
$56M
49%
← FY 2022
All Quarters
Q1 2023 →